Lansforsakringar Fondforvaltning’s Boston Scientific BSX Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$67.5M	Buy	1,581,108 +687,359	+77%	+$37.3M	0.3%	57
2026 Q1	$56.1M	Buy	893,749 +102,573	+13%	+$8.21M	0.29%	66
2025 Q4	$75.4M	Sell	791,176 -4,913	-0.6%	-$482K	0.37%	45
2025 Q3	$77.7M	Sell	796,089 -28,276	-3%	-$2.93M	0.4%	39
2025 Q2	$88.5M	Sell	824,365 -35,191	-4%	-$3.56M	0.51%	29
2025 Q1	$86.7M	Sell	859,556 -7,527	-0.9%	-$758K	0.53%	31
2024 Q4	$77.4M	Buy	+867,083	New	+$76.3M	0.43%	42

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lansforsakringar Fondforvaltning's BSX Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning increased its Boston Scientific (BSX) stake by 77% in Q2 2026, buying an estimated $37.3M and bringing the position to 1,581,108 shares worth $67.5M. The position accounts for 0.3% of the portfolio, ranked #57.

Lansforsakringar Fondforvaltning first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $88.5M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Lansforsakringar Fondforvaltning held 1,581,108 shares of Boston Scientific worth $67.5M as of Q2 2026.
Lansforsakringar Fondforvaltning bought 687,359 Boston Scientific shares in Q2 2026, an estimated $37.3M.
Boston Scientific made up 0.3% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #57 holding.
Lansforsakringar Fondforvaltning first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
Lansforsakringar Fondforvaltning's Boston Scientific position peaked at $88.5M in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.